Clinical trials
Trials in Iraq with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
310 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 21 |
| 2022 | 41 |
| 2023 | 33 |
| 2024 | 48 |
| 2025 | 57 |
| 2026 | 62 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 169 |
| Unknown status | 45 |
| Not yet recruiting | 32 |
| Recruiting | 32 |
| Active, not recruiting | 25 |
| Enrolling by invitation | 4 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Baghdad | 105 |
| Hawler Medical University | 34 |
| Al-Mustansiriyah University | 16 |
| University of Sulaimani | 11 |
| Kufa University | 9 |
| Karbala University | 6 |
| University of Mosul | 6 |
| Al-Rasheed University College | 5 |
| Omer Othman Abdullah | 5 |
| University of Duhok | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Periodontitis | 12 |
| Pain | 10 |
| Anxiety Disorders | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Agnosia | 5 |
| Kidney Failure, Chronic | 5 |
| Periodontal Diseases | 5 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Fatigue | 4 |
Trials
Showing 51 to 75 of 310. Each trial links to its page on Pharma Observatory.
210 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.